Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:38:02 EDT Thu 10 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:VYGR
- VOYAGER THERAPEUTICS INC -
Website unknown - click to update
20:38:02 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
VYGR
- Q
0.4
3.50
·
4.11
0.1
3.55
+0.08
2.3
935.4
3,138
3,870
3.50
3.72
3.50
9.55 2.645
19:59:19
Jun 10
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 3870
More trades...
Time ET
Ex
Price
Change
Volume
19:59:19
Q
3.72
0.25
3,900
19:59:18
Q
3.72
0.25
3,800
19:58:24
Q
3.72
0.25
100
19:57:59
Q
3.79
0.32
1
19:55:04
Q
3.79
0.32
3
19:24:02
Q
3.799
0.329
9
19:18:40
Q
3.7997
0.3297
100
19:09:24
Q
3.76
0.29
90
19:05:49
Q
3.72
0.25
1
18:56:57
Q
3.72
0.25
50
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-10 07:01
U:VYGR
News Release
200
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
2025-05-15 07:01
U:VYGR
News Release
200
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication
2025-05-06 16:01
U:VYGR
News Release
200
Voyager Reports First Quarter 2025 Financial and Operating Results
2025-04-28 16:30
U:VYGR
News Release
200
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
2025-03-31 07:01
U:VYGR
News Release
200
Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD(TM) 2025
2025-03-11 16:01
U:VYGR
News Release
200
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
2025-03-04 07:00
U:VYGR
News Release
200
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
2025-03-03 07:00
U:VYGR
News Release
200
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease
2025-02-25 07:00
U:VYGR
News Release
200
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
2025-02-11 07:00
U:VYGR
News Release
200
Voyager Provides Update on SOD1 ALS Gene Therapy Program
2025-02-06 07:00
U:VYGR
News Release
200
Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference
2024-11-20 07:00
U:VYGR
News Release
200
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease
2024-11-12 16:01
U:VYGR
News Release
200
Voyager Reports Third Quarter 2024 Financial and Operating Results
2024-11-06 07:00
U:VYGR
News Release
200
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
2024-11-05 07:00
U:VYGR
News Release
200
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
2024-09-16 07:00
U:VYGR
News Release
200
Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected
2024-09-05 08:00
U:VYGR
News Release
200
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
2024-08-29 16:01
U:VYGR
News Release
200
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-08-29 07:00
U:VYGR
News Release
200
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
2024-08-07 07:00
U:VYGR
News Release
200
Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase